source
- EGFR-Mutated NSCLC: Molecular Reassessment at Disease ProgressionIn this case-based segment, Dr. Sands presents a patient with EGFR-mutated metastatic non-small cell lung cancer who has progressed after first-line combination therapy with an EGFR tyrosine kinase…onclive · 3mo ago↗ source
- New Understandings of Treatments, End Points, and Disease Biology Expand MCL HorizonsLore Gruenbaum, PhD, discusses the direction mantle cell lymphoma is headed in addition to other critical areas of unmet needs.onclive · 3mo ago↗ source
- Fierce Biotech Layoff Tracker 2026: Kolon cuts workforce after ph. 3 fail; Sanofi sheds 229 staffersAs always, if you know of layoffs occurring at a biotech, please reach out to the Fierce Biotech editorial team.Fierce Biotech